Revolutionary U of A biopsy-reading invention reaches the masses
A groundbreaking University of Alberta invention that will impact transplant patients’ outcomes—and possibly cancer outcomes in the future—is poised to become widely available now that the transplant test has been licensed by life science leader Thermo Fisher.
The diagnostic tool is a major advancement on existing biopsy approaches for transplant organs because it relies on precise gene expression measurement. Called MMDx (Molecular Microscope Diagnostic System), it was created by Philip Halloran and his team at the U of A spin-off company Transcriptome Sciences Inc.